Investigation of in vitro activities of fluconazole, itraconazole and voriconazole against clinical isolates of blastoschizomyces capitatus (geotrichum capitatum) by two different methods;Flukonazol, i̇trakonazol ve vori̇konazolün kli̇ni̇k blastoschizomyces capitatus (geotrichum capitatum) i̇zolatlarina karşi i̇n vi̇tro akti̇vi̇tesvni̇n i̇ki̇ farkli yöntemle araştirilmasi

Mikrobiyoloji Bulteni

Volumn 43, Issue 2, 2009, Pages 269-276

  Sancak, Banu ^a   Alp, Şehnaz ^a   Hasçelik, Gulşen ^a   Arikan, Sevtap ^a  

^a HACETTEPE UNIVERSITY   (Turkey)

Author keywords

Blastoschizomyces capitatus; Etest; Fluconazole; In vitro susceptibility; Itraconazole; Microdilution; Voriconazole

Indexed keywords

ANTIFUNGAL AGENT; FLUCONAZOLE; ITRACONAZOLE; PYRIMIDINE DERIVATIVE; TRIAZOLE DERIVATIVE; VORICONAZOLE;

ARTICLE; DIPODASCUS; DRUG EFFECT; GEOTRICHOSIS; HUMAN; METHODOLOGY; MICROBIOLOGICAL EXAMINATION; MICROBIOLOGY; OPPORTUNISTIC INFECTION;

ANTIFUNGAL AGENTS; DIPODASCUS; FLUCONAZOLE; GEOTRICHOSIS; HUMANS; ITRACONAZOLE; MICROBIAL SENSITIVITY TESTS; OPPORTUNISTIC INFECTIONS; PYRIMIDINES; TRIAZOLES;

EID: 67649516792     PISSN: 03749096     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (18)

1. Kauffman CA. The changing landscape of invasive fungal infections: epidemiology, diagnosis, and pharma-cologic options. Clin Infect Dis 2006; 43 (Suppl 1): 1-2.
2. Walsh TJ, Groll A, Hiemenz J, Fleming R, Roilides E, Anaissie E. Infections due to emerging and uncommon medically important fungal pathogens. Clin Microbiol Infect 2004; 10 (Suppl 1): 48-66.
3. Pfaller MA, Diekema DJ. Rare and emerging opportunistic fungal pathogens: concern for resistance beyond Candida albicans and Aspergillus fumigatus. J Clin Microbiol 2004; 42: 4419-31.
4. Alexander BD, Pfaller MA. Contemporary tools for the diagnosis and management of invasive mycoses. Clin Infect Dis 2006; 43:15-27.
5. rd ed. ASM Press, Washington, DC.
6. Bouza E, Muñoz P. Invasive infections caused by Blastoschizomyces capitatus and Scedosporium spp. Clin Microbiol Infect 2004; 10 (Suppl 1): 76-85.
7. D'Antonio D, Romano F, lacone A, et al. Onychomycosis caused by Blastoschizomyces capitatus. J Clin Microbiol 1999; 37:2927-30.
8. Martino P, Venditti M, Micozzi A, et al. Blastoschizomyces capitatus: an emerging cause of invasive fungal disease in leukemia patients. Rev Infect Dis 1990; 12: 570-82.
9. Martino R, Salavert M, Parody R, et al. Blastoschizomyces capitatus infection in patients with leukemia: report of 26 cases. Clin Infect Dis 2004; 38: 335-41.
10. D'Antonio D, Mazzoni A, lacone A, et al. Emergence of fluconazole-resistant strains of Blastoschizomyces capitatus causing nosocomial infections in cancer patients. J Clin Microbiol 1996; 34: 753-5.
11. nd ed. NCCLS/CLSI, Wayne, Pa.
12. Girmenia C, Pizzarelli G, D'Antonio D, Cristini F, Martino P. In vitro susceptibility testing of Geotrichum capitatum: Comparison of the Etest, disk diffusion, and sensititre colorimetric methods with the NCCLS M27-A2 broth microdilution reference method. Antimicrob Agents Chemother 2003; 47: 3985-8.
13. Metin DY, Hilmioǧlu-Polat S, Bozkurt H, Inci R, Tümbay E. Klinik örneklerden soyutlanan Blastoschizomyces capitatus (Geotrichum capitatum) kökenlerinin antifungal ilaçlara mikrodilüsyon ve Etest ile in vitro duyarliliklan. 5.UIusal Mantar Hastahklan ve Klinik Mikoloji Kongresi, 20-23 Haziran 2007, Çanakkale. Infeksiyon Derg 2007; 21 (Suppl): 230.
14. th European Congress of Clinical Microbiology and Infectious Diseases. Copenhagen, Denmark, April 2-5, 2005.
15. Serena C, Mariné M, Marimon R, Pastor FJ, Guarro J. Effect of antifungal treatment in a murine model of blastoschizomycosis. Int J Antimicrob Agents 2007; 29: 79-83.
16. Espinel-lngroff A. In vitro activity of the new triazole voriconazole (UK-109,496) against opportunistic filamentous and dimorphic fungi and common and emerging yeast pathogens. J Clin Microbiol 1998; 36: 198-202.
17. Girmenia C, Pagano L, Martino B, et al; GIMEMA Infection Program. Invasive infections caused by Trichosporon species and Geotrichum capitatum in patients with hematological malignancies: a retrospective mul-ticenter study from Italy and review of the literature. J Clin Microbiol 2005; 43: 1818-28.
18. Groll AH, Walsh TH. Uncommon opportunistic fungi: new nosocomial threats. Clin Microbiol Infect 2001; 7 (Suppl 2): 8-24.